Pharma

By Jonah Comstock 09:04 am May 9, 2019
Working with pharma giant Eli Lilly and Company, chronic disease management company Livongo has completed a retrospective analysis of more than 10,000 paitents, which suggests that Livongo's diabetes program can prevent $88 worth of medical spending per person per month.  Citing an average cost to employers of $68 per person per month, including about $30 worth of diabetes management products,...
By Dave Muoio 01:13 pm May 6, 2019
Editor's Note: An original headline for this story contained an error, and has since been corrected. Boston- and San Francisco-based Pear Therapeutics, maker of prescription digital therapeutics for substance abuse, has kicked off a feasibility study for Pear-006, an in-development treatment for depressive symptoms in those with multiple sclerosis (MS). Pear Therapeutics has been developing Pear-...
By Laura Lovett 11:36 am April 30, 2019
Medisafe, a digital medication adherence app, is joining forces with Amerisource Bergen’s Lash Group in order to integrate the former’s management app into the latter’s hub services. The partnership seeks to help patients manage their medications and identify patients who need extra support.  As part of the deal Lash patients will be able to enroll in the Medisafe platform when  medication is...

23andMe kits at a Beverly Hills event in 2017. Credit: Matt Winkelmeyer, Getty Images

By Laura Lovett 03:14 pm April 29, 2019
This morning 23andMe announced that it is teaming up with The Michael J. Fox Foundation for Parkinson’s Research on a new data and analytics platform dedicated to Parkinson’s research.  The new tool, dubbed Fox Insight Data Exploration Network (Fox DEN) is set to include patient surveys, de-identified genetic data and data exploration tools all aimed studying Parkinson’s.  Users who opt into the...
By Jonah Comstock 07:39 pm April 25, 2019
Diplomat Pharmacy has released some data about its partnership with smart pill bottle maker AdhereTech as the companies also announced plans to expand that deal. The data, representative of more than 1,000 patients, shows that on average, patients who used the technology filled their medication one additional time over the course of the year. Patient retention was 12% higher, and the average...
By Dave Muoio 03:14 pm April 9, 2019
Although still in its earliest chapters, the story of digital therapeutics is beginning to pick up steam. Just six months ago, that the first software-only therapeutic cleared by the FDA, Pear Therapeutics’ reSET, kicked off a commercial launch driven by the sales channels expertise of an established pharmaceutical partner. Proteus, meanwhile, recently expanded dealings with its long-time pharma...
By Dave Muoio 12:00 pm April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
By Jonah Comstock 02:41 pm March 29, 2019
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage about the work the top Israeli pharma company has been doing in digital health. These topics included the company's recently FDA-cleared smart inhaler ProAir Digihaler, as well as more broad...
By Dave Muoio 01:13 pm March 29, 2019
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses. According to the announcement, Concerto’s eurekaHealth tool will “accelerate insights through novel health economic...
By Laura Lovett 03:28 pm March 28, 2019
Within the last few years the FDA has undergone a metamorphosis when it comes to digital health regulations. Though many of these are not yet solidified, a recent report by PricewaterhouseCoopers (PwC) predicts that these changes could open new doors for pharmaceutical companies looking to jump into the digital arena.  “Changes made by the FDA have made it easier for digital health products to be...